Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial.
Weidner N, Abel R, Maier D, Röhl K, Röhrich F, Baumberger M, Hund-Georgiadis M, Saur M, Benito J, Rehahn K, Aach M, Badke A, Kriz J, Barkovits K, Killeen T, Farner L, Seif M, Hubli M, Marcus K, Maurer MA, Robert B, Rupp R, Scheuren PS, Schubert M, Schuld C, Sina C, Steiner B, Weis T, Hug A, Bolliger M, Weiskopf N, Freund P, Hothorn T, Schwab ME, Curt A; Nogo Inhibition in Spinal Cord Injury Study Group. Weidner N, et al. Among authors: abel r. Lancet Neurol. 2025 Jan;24(1):42-53. doi: 10.1016/S1474-4422(24)00447-2. Lancet Neurol. 2025. PMID: 39706632 Free article. Clinical Trial.
Toward Inclusive Trial Protocols in Heterogeneous Neurological Disorders: Prediction-Based Stratification of Participants With Incomplete Cervical Spinal Cord Injury.
Tanadini LG, Hothorn T, Jones LA, Lammertse DP, Abel R, Maier D, Rupp R, Weidner N, Curt A, Steeves JD. Tanadini LG, et al. Among authors: abel r. Neurorehabil Neural Repair. 2015 Oct;29(9):867-77. doi: 10.1177/1545968315570322. Epub 2015 Feb 2. Neurorehabil Neural Repair. 2015. PMID: 25644238
First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury.
Kucher K, Johns D, Maier D, Abel R, Badke A, Baron H, Thietje R, Casha S, Meindl R, Gomez-Mancilla B, Pfister C, Rupp R, Weidner N, Mir A, Schwab ME, Curt A. Kucher K, et al. Among authors: abel r. Neurorehabil Neural Repair. 2018 Jun;32(6-7):578-589. doi: 10.1177/1545968318776371. Epub 2018 Jun 5. Neurorehabil Neural Repair. 2018. PMID: 29869587 Clinical Trial.
Inclusive Trial Designs in Acute Spinal Cord Injuries: Prediction-Based Stratification of Clinical Walking Outcome and Projected Enrolment Frequencies.
Cathomen A, Sirucek L, Killeen T, Abel R, Maier D, Weidner N, Rupp R, Hothorn T, Steeves JD, Curt A, Bolliger M. Cathomen A, et al. Among authors: abel r. Neurorehabil Neural Repair. 2022 Apr;36(4-5):274-285. doi: 10.1177/15459683221078302. Epub 2022 Feb 14. Neurorehabil Neural Repair. 2022. PMID: 35164574 Free PMC article.
Prediction and stratification of upper limb function and self-care in acute cervical spinal cord injury with the graded redefined assessment of strength, sensibility, and prehension (GRASSP).
Velstra IM, Bolliger M, Tanadini LG, Baumberger M, Abel R, Rietman JS, Curt A. Velstra IM, et al. Among authors: abel r. Neurorehabil Neural Repair. 2014 Sep;28(7):632-42. doi: 10.1177/1545968314521695. Epub 2014 Feb 24. Neurorehabil Neural Repair. 2014. PMID: 24566986
531 results